Top compounds associated with response to FAM131A


Feature Type Standardized
Nominal ANOVA
mRNA Erlotinib gCSI pan-cancer AAC -0.12 0.06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.06
mRNA pitstop2 CTRPv2 pan-cancer AAC 0.091 0.06
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.073 0.06
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.065 0.06
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.076 0.07
mRNA COL-3 CTRPv2 pan-cancer AAC -0.073 0.07
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.07
mRNA Irinotecan gCSI pan-cancer AAC -0.11 0.07
mRNA ifosfamide CTRPv2 pan-cancer AAC -0.11 0.07
Download CSV